These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Natural history of open-angle glaucoma. Heijl A, Bengtsson B, Hyman L, Leske MC, Early Manifest Glaucoma Trial Group. Ophthalmology; 2009 Dec; 116(12):2271-6. PubMed ID: 19854514 [Abstract] [Full Text] [Related]
5. Scoring systems for measuring progression of visual field loss in clinical trials of glaucoma treatment. Katz J. Ophthalmology; 1999 Feb; 106(2):391-5. PubMed ID: 9951496 [Abstract] [Full Text] [Related]
8. The European Glaucoma Prevention Study and the Ocular Hypertension Treatment Study: why do two studies have different results? Parrish RK. Curr Opin Ophthalmol; 2006 Apr; 17(2):138-41. PubMed ID: 16552248 [Abstract] [Full Text] [Related]
9. Predictive factors for open-angle glaucoma among patients with ocular hypertension in the European Glaucoma Prevention Study. European Glaucoma Prevention Study (EGPS) GroupUniversità di Milano Bicocca, Policlinico di Monza, Via Amati 111, 20052, Monza, Mi, Italy. stefano.miglior@unimib.it, Miglior S, Pfeiffer N, Torri V, Zeyen T, Cunha-Vaz J, Adamsons I. Ophthalmology; 2007 Jan; 114(1):3-9. PubMed ID: 17070596 [Abstract] [Full Text] [Related]
10. Intraocular pressure fluctuation a risk factor for visual field progression at low intraocular pressures in the advanced glaucoma intervention study. Caprioli J, Coleman AL. Ophthalmology; 2008 Jul; 115(7):1123-1129.e3. PubMed ID: 18082889 [Abstract] [Full Text] [Related]
11. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study. Martínez A, Sánchez M. Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468 [Abstract] [Full Text] [Related]